9.83
price up icon1.55%   0.15
after-market Dopo l'orario di chiusura: 9.81 -0.02 -0.20%
loading
Precedente Chiudi:
$9.68
Aprire:
$9.58
Volume 24 ore:
174.27K
Relative Volume:
0.64
Capitalizzazione di mercato:
$216.30M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-10.46
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
+0.92%
1M Prestazione:
+11.07%
6M Prestazione:
+226.58%
1 anno Prestazione:
+233.22%
Intervallo 1D:
Value
$9.51
$9.9309
Intervallo di 1 settimana:
Value
$9.4801
$10.00
Portata 52W:
Value
$2.38
$10.34

Exagen Inc Stock (XGN) Company Profile

Name
Nome
Exagen Inc
Name
Telefono
(760) 560-1501
Name
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Name
Dipendente
209
Name
Cinguettio
@ExagenInc
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
XGN's Discussions on Twitter

Confronta XGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
XGN
Exagen Inc
9.83 211.45M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
489.49 184.10B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
199.03 145.92B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
640.44 51.16B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
128.48 35.50B 6.79B 1.22B 1.09B 4.26
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
184.08 31.24B 15.70B 1.24B 2.01B 6.91

Exagen Inc Stock (XGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-30 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2025-07-23 Iniziato Craig Hallum Buy
2022-08-05 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 Ripresa Cowen Outperform
2021-04-15 Iniziato Canaccord Genuity Buy
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2020-10-08 Iniziato BTIG Research Buy
2020-06-02 Ripresa Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cowen Outperform
2019-10-14 Iniziato William Blair Outperform
Mostra tutto

Exagen Inc Borsa (XGN) Ultime notizie

pulisher
Sep 03, 2025

Using AI based signals to follow Exagen Inc.July 2025 Decliners & Free Daily Entry Point Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Intraday pattern recognizer results for Exagen Inc.Quarterly Market Review & Momentum Based Trading Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Exagen Inc. stock momentum explainedJuly 2025 Reactions & Consistent Income Trade Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Exagen Inc. stock trend forecast2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time pattern detection on Exagen Inc. stock2025 Trading Volume Trends & Daily Growth Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Exagen Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 03, 2025
pulisher
Sep 03, 2025

How to forecast Exagen Inc. trends using time series2025 Top Gainers & Community Verified Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tools to assess Exagen Inc.’s risk profile2025 Market Outlook & Expert Curated Trade Setups - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Smart tools for monitoring Exagen Inc.’s price actionPortfolio Growth Summary & Expert Approved Momentum Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can technical indicators confirm Exagen Inc.’s reversalEarnings Summary Report & Daily Momentum Trading Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What’s the analyst consensus on Exagen Inc.July 2025 Sentiment & Verified Entry Point Detection - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

What the charts say about Exagen Inc. todayM&A Rumor & Community Trade Idea Sharing Platform - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Exagen Inc. exposed to political risk2025 Dividend Review & Low Risk Investment Opportunities - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Using R and stats models for Exagen Inc. forecastingExit Point & Entry Point Confirmation Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Volume spikes in Exagen Inc. stock – what they meanGap Up & Weekly Chart Analysis and Trade Guides - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What risks could impact Exagen Inc. stock performance2025 Top Gainers & Daily Chart Pattern Signal Reports - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Will Exagen Inc. benefit from AI trendsJuly 2025 Outlook & Reliable Trade Execution Plans - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Exagen Inc.’s Beta Climbs After Market Volatility getLinesFromResByArray error: size == 0 - 더경남뉴스

Sep 01, 2025
pulisher
Sep 01, 2025

Is It Too Late to Sell Exagen Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr

Sep 01, 2025
pulisher
Aug 31, 2025

Will Exagen Inc. price bounce be sustainableForecast Cut & AI Driven Stock Movement Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Fibonacci Retracement Aligns with Support in Exagen Inc.Market Growth Summary & AI Optimized Trading Strategy Guides - beatles.ru

Aug 31, 2025
pulisher
Aug 31, 2025

Risk adjusted return profile for Exagen Inc. analyzedBuy Signal & Low Risk High Reward Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Exagen Inc. stock reversal real or fakeMarket Activity Report & Safe Capital Allocation Plans - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Market reaction to Exagen Inc.’s recent news2025 Biggest Moves & Safe Swing Trade Setups - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

How to use a screener to detect Exagen Inc. breakoutsJuly 2025 Action & AI Enhanced Trading Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Comparing Exagen Inc. in custom built stock radarsTrend Reversal & Entry and Exit Point Strategies - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Exagen Inc. stock daily chart insightsEarnings Beat & Reliable Trade Execution Plans - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Multi Factor Analysis Ranks Exagen Inc. as Strong Buy getLinesFromResByArray error: size == 0 - kangso.co.kr

Aug 30, 2025
pulisher
Aug 30, 2025

Is Exagen Inc. reversing from oversold territoryJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Building trade automation scripts for Exagen Inc.Product Launch & Real-Time Stock Movement Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is There Enough Volume to Lift Exagen Inc. getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 30, 2025

Exagen Inc Azioni (XGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Exagen Inc Azioni (XGN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
NMSIC Co-Investment Fund, L.P.
10% Owner
Nov 20 '24
Sale
3.30
200,000
660,040
2,108,958
Black Jeffrey G.
Chief Financial Officer
Nov 15 '24
Buy
2.98
22,298
66,448
274,492
ABALLI JOHN
President and CEO
Nov 14 '24
Buy
2.81
24,305
68,297
689,799
diagnostics_research WAT
$299.69
price up icon 3.32%
diagnostics_research DGX
$180.11
price up icon 0.33%
$166.56
price down icon 0.58%
diagnostics_research LH
$275.23
price up icon 0.51%
diagnostics_research MTD
$1,287.79
price up icon 1.51%
diagnostics_research IQV
$184.08
price down icon 0.29%
Capitalizzazione:     |  Volume (24 ore):